These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15096454)

  • 1. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.
    Lips DJ; Bueno OF; Wilkins BJ; Purcell NH; Kaiser RA; Lorenz JN; Voisin L; Saba-El-Leil MK; Meloche S; Pouysségur J; Pagès G; De Windt LJ; Doevendans PA; Molkentin JD
    Circulation; 2004 Apr; 109(16):1938-41. PubMed ID: 15096454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.
    Bueno OF; De Windt LJ; Tymitz KM; Witt SA; Kimball TR; Klevitsky R; Hewett TE; Jones SP; Lefer DJ; Peng CF; Kitsis RN; Molkentin JD
    EMBO J; 2000 Dec; 19(23):6341-50. PubMed ID: 11101507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
    Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S; Tosaki A; Bagchi D; Maulik N; Das DK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
    Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
    Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
    Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
    Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of G-protein signaling 5 protects cardiomyocytes against apoptosis during in vitro cardiac ischemia-reperfusion in mice by inhibiting both JNK1/2 and P38 signaling pathways.
    Wang Z; Huang H; He W; Kong B; Hu H; Fan Y; Liao J; Wang L; Mei Y; Liu W; Xiong X; Peng J; Xiao Y; Huang D; Quan D; Li Q; Xiong L; Zhong P; Wang G
    Biochem Biophys Res Commun; 2016 Apr; 473(2):551-7. PubMed ID: 27021681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.
    Ueyama T; Kawashima S; Sakoda T; Rikitake Y; Ishida T; Kawai M; Yamashita T; Ishido S; Hotta H; Yokoyama M
    J Mol Cell Cardiol; 2000 Jun; 32(6):947-60. PubMed ID: 10888249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning.
    Takeishi Y; Huang Q; Wang T; Glassman M; Yoshizumi M; Baines CP; Lee JD; Kawakatsu H; Che W; Lerner-Marmarosh N; Zhang C; Yan C; Ohta S; Walsh RA; Berk BC; Abe J
    J Mol Cell Cardiol; 2001 Nov; 33(11):1989-2005. PubMed ID: 11708843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.
    Sasaki T; Shishido T; Kadowaki S; Kitahara T; Suzuki S; Katoh S; Funayama A; Netsu S; Watanabe T; Goto K; Takeishi Y; Kubota I
    Heart Vessels; 2014 Jan; 29(1):110-8. PubMed ID: 23719772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Na+/H+ exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium.
    Moor AN; Gan XT; Karmazyn M; Fliegel L
    J Biol Chem; 2001 May; 276(19):16113-22. PubMed ID: 11279085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.
    Purcell NH; Wilkins BJ; York A; Saba-El-Leil MK; Meloche S; Robbins J; Molkentin JD
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14074-9. PubMed ID: 17709754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass.
    Talmor D; Applebaum A; Rudich A; Shapira Y; Tirosh A
    Circ Res; 2000 May; 86(9):1004-7. PubMed ID: 10807874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice].
    Li XM; Ma YT; Yang YN; Zhang JF; Chen BD; Liu F; Huang Y; Han W; Gao XM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):846-50. PubMed ID: 19595127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.
    Bueno OF; Molkentin JD
    Circ Res; 2002 Nov; 91(9):776-81. PubMed ID: 12411391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.
    Kehat I; Davis J; Tiburcy M; Accornero F; Saba-El-Leil MK; Maillet M; York AJ; Lorenz JN; Zimmermann WH; Meloche S; Molkentin JD
    Circ Res; 2011 Jan; 108(2):176-83. PubMed ID: 21127295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.